![Jason Hanson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Hanson
Director/Board Member at
BULLFROG AI HOLDINGS, INC.
Net worth: 2 132 $ as of 2026-05-30
Profile
Jason D.
Hanson is an Independent Non-Executive Director at BullFrog AI Holdings, Inc. since 2023.
Formerly, Mr. Hanson was President, Chief Executive Officer & Director at enGene, Inc. from 2018 to 2024, and Chief Executive Officer & Executive Director at enGene Therapeutics, Inc. from 2023 to 2024.
Served as Chairman & Executive Vice President at Bausch Health Cos., Inc. from 2012 to 2013.
Held the position of Director at Ohana Biosciences, Inc. from 2017 to 2018 and at The Electronic Transactions Association.
Was Chief Operating Officer & Executive Vice President at Medicis Pharmaceutical Corp.
from 2011 to 2012.
Worked as EVP-Strategy, Development & General Counsel at NuVasive LLC from 2015 to 2016.
Served as General Counsel-Americas at GE Medical Systems, Inc. from 1999 to 2004.
Held the role of Vice President & General Counsel at GE Healthcare AG.
Was Vice President at GE Aerospace from 2014 to 2015.
Worked as General Counsel at GE Healthcare IVD Technologies in 2006.
Education includes undergraduate studies at Cornell University and graduate studies at Duke University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 2,813 ( 0.02% ) | 2 132 $ | 2026-05-30 |
Jason Hanson active positions
| Companies | Position | Start |
|---|---|---|
| BULLFROG AI HOLDINGS, INC. | Director/Board Member | 2023-02-13 |
Former positions of Jason Hanson
| Companies | Position | End |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Chief Executive Officer | 2024-07-20 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Chief Executive Officer | 2024-07-20 |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Chief Executive Officer | 2017-10-31 |
| NUVASIVE, INC. | General Counsel | 2016-07-31 |
| GE AEROSPACE | Corporate Officer/Principal | 2015-09-30 |
Training of Jason Hanson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
GE Aerospace
 GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
GE Medical Systems, Inc.
 GE Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic imaging and medical monitoring systems as well as provides information technology services to health care providers | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GE Healthcare IVD Technologies
 GE Healthcare IVD Technologies Medical DistributorsDistribution Services Supplies medical equipment | Distribution Services |
The Electronic Transactions Association
 The Electronic Transactions Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association for digital payments industry | Commercial Services |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
GE Healthcare AG
 GE Healthcare AG BiotechnologyHealth Technology Provides biotechnology and transformational medical technologies and services | Health Technology |
Duke University School of Law
 Duke University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Commercial Services |
BullFrog AI Holdings, Inc.
 BullFrog AI Holdings, Inc. Packaged SoftwareTechnology Services Develops an artificial intelligence and machine learning platform for clinical and pharmaceutical industry | Technology Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Jason Hanson
